Trials / Completed
CompletedNCT06166992
A Study in Healthy Men to Test How BI 1291583 is Taken up by the Body
Investigation of Pharmacokinetics and Absolute Oral Bioavailability of BI 1291583 Administered as an Oral Dose With an Intravenous Microtracer Dose of [14C]-BI 1291583 in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the absolute bioavailability of BI 1291583 (test treatment T, not radio-labelled) compared with BI 1291583 (C-14) (reference treatment R).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BI 1291583 | BI 1291583 |
| DRUG | [14C]-BI 1291583 | \[14C\]-BI 1291583 |
Timeline
- Start date
- 2023-12-12
- Primary completion
- 2024-02-07
- Completion
- 2024-02-07
- First posted
- 2023-12-12
- Last updated
- 2025-08-13
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT06166992. Inclusion in this directory is not an endorsement.